Market revenue in 2023 | USD 240.1 million |
Market revenue in 2030 | USD 403.9 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.48% in 2023. Horizon Databook has segmented the China diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
The regulatory process for product approvals is comparatively less stringent in China, facilitating easy entry of advanced products into the market. In addition, availability of resources enables technological advancements at cheaper costs, which has led to an increase in the number of manufacturing facilities in the country.
In addition, China released Order 650 (former Order 276), Regulations for the Supervision and Administration of Medical Devices, to restrict foreign investment in the country, primarily to protect local medical device manufacturers. Hence, the number of local wound dressing manufacturers is anticipated to increase, owing to which the market is expected to grow over the forecast period.
Companies interested in entering China must overcome existing barriers in an ambiguous and changing regulatory environment. The country also offers high potential for U.S. companies interested in expanding and entering into the China diabetic foot ulcer treatment market.
Horizon Databook provides a detailed overview of country-level data and insights on the China diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into China diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account